2 options
Ashp best practices 2016-2017 edition : position & guidance documents of Ashp / Bruce Hawkins, editor.
- Format:
- Book
- Language:
- English
- Subjects (All):
- Hospital pharmacies--Standards--United States.
- Hospital pharmacies.
- Pharmacy--Standards--United States.
- Pharmacy.
- Physical Description:
- 1 online resource (768 pages)
- Edition:
- 1st ed.
- Other Title:
- American Society of Health-System Pharmacists best practices 2016-2017 edition
- Place of Publication:
- Wisconsin : ASHP Publications, 2016.
- Summary:
- The most comprehensive set of quality guidelines available to the pharmacy profession. More than half a century ago, ASHP® developed its earliest proposed practice standard--the Proposed Minimum Standards for Pharmacies in Hospitals. Today, ASHP continues to foster concrete improvements in pharmacy practice and in the therapeutic use of drugs with its annual compilation of ASHP guidance documents: ASHP Best Practices. These guidance documents have stimulated improvements in pharmacy practice and operations, influenced accreditation standards, laws, and regulations (both in the United States and in other countries), and contributed to an awareness among consumers and policymakers of the vital patient care role of pharmacists. INSIDE: ASHP positions and more than 70 ASHP guidance documents of varying scope that provide ongoing advice to practitioners and health systems to help improve the medication-use process, patient care and safety, and patient outcomes and quality of life.
- Contents:
- Intro
- Contents
- Page Locator for Guidance Documents by Type and Title
- Acknowledgments
- Introduction
- Mission Statement of the American Society of Health-System Pharmacists (ASHP)
- Vision Statement of the American Society of Health-System Pharmacists (ASHP)
- ASHP Policy Positions, Statements, Guidelines, and Technical Assistance Bulletins
- Automation and Information Technology
- Positions
- Therapeutic Indication in Clinical Decision Support Systems (1608)
- Automated Preparation and Dispensing Technology for Sterile Preparations (1617)
- Online Pharmacy and Internet Prescribing (1529)
- Risk Assessment of Health Information Technology (1418)
- Interoperability of Patient-Care Technologies (1302)
- Pharmacist's Role in Health Care Information Systems (1211)
- Clinical Decision Support Systems (1212)
- Definition of Meaningful Use of Health Information Technology (1006)
- Role of Pharmacists in Safe Technology Implementation(1020)
- Electronic Health and Business Technology and Services(0712)
- Electronic Information Systems (0507)
- Computerized Prescriber Order Entry (0105)
- Telepharmacy (9920)
- Regulation of Automated Drug Distribution Systems (9813)
- Statements
- ASHP Statement on Bar-Code-Enabled Medication Administration Technology
- ASHP Statement on Bar-Code Verification During Inventory, Preparation, and Dispensing of Medications
- ASHP Statement on the Pharmacist's Role in Clinical Informatics
- ASHP Statement on the Pharmacist's Role with Respect to Drug Delivery Systems and Administration Devices
- ASHP Statement on the Pharmacy Technician's Role in Pharmacy Informatics
- ASHP Statement on Use of Social Media by Pharmacy Professionals
- Guidelines.
- ASHP Guidelines on the Design of Database-Driven Clinical Decision Support: Strategic Directions for Drug Database and Electronic Health Records Vendors
- ASHP Guidelines on Pharmacy Planning for Implementation of Computerized Provider-Order-Entry Systems in Hospitals and Health Systems
- ASHP Guidelines on Remote Medication Order Processing
- ASHP Guidelines on the Safe Use of Automated Compounding Devices for the Preparation of Parenteral Nutrition Admixtures
- ASHP Guidelines on the Safe Use of Automated Dispensing Devices
- Drug Distribution and Control
- Redistribution of Unused Medications (0611)
- Pharmaceutical Counterfeiting (0401)
- Pharmacy Drug Theft (0303)
- Pharmacist's Role in Drug Procurement, Distribution, Surveillance, and Control (0232)
- Optimizing the Medication-Use Process (9903)
- Procurement
- Guidelines
- ASHP Guidelines on Managing Drug Product Shortages in Hospitals and Health Systems
- ASHP Guidelines for Selecting Pharmaceutical Manufacturers and Suppliers
- Preparation and Handling
- Pharmaceutical Waste (0903)
- Safe Disposal of Patients' Home Medications (0614)
- Safe and Effective Extemporaneous Compounding (0616)
- ASHP Guidelines on Compounding Sterile Preparations
- ASHP Guidelines on Handling Hazardous Drugs
- ASHP Guidelines on Pharmacy-Prepared Ophthalmic Products
- Technical Assistance Bulletin
- ASHP Technical Assistance Bulletin on Compounding Nonsterile Products in Pharmacies
- Distribution
- Technician-Checking- Technician Programs (0310)
- Dispensing by Nonpharmacists and Nonprescribers (0010)
- ASHP Statement on Pharmacist's Responsibility for Distribution and Control of Drug Products
- ASHP Statement on Unit Dose Drug Distribution
- Technical Assistance Bulletin.
- ASHP Technical Assistance Bulletin on Hospital Drug Distribution and Control
- ASHP Technical Assistance Bulletin on Repackaging Oral Solids and Liquids in Single Unit and Unit Dose Packages
- ASHP Technical Assistance Bulletin on Single Unit and Unit Dose Packages of Drugs
- Education and Training
- Pharmacy Technician Training and Certification (1609)
- Developing Leadership Competencies (1611)
- Interprofessional Education and Training (1612)
- Cultural Competency (1613)
- Pharmacy Resident and Student Roles in New Practice Models (1316)
- Education and Training in Health Care Informatics (1317)
- Preceptor Skills and Abilities (1201)
- Qualifications of Pharmacy Technicians in Advanced Roles (1203)
- Quality of Pharmacy Education and Expansion of Colleges of Pharmacy (1108)
- Residency Equivalency (1109)
- Pharmacy Internships (1110)
- State-Specific Requirements for Pharmacist Continuing Education (1111)
- Innovative Residency Models (1112)
- Employment Classification and Duty Hours of Pharmacy Residents (1008)
- Pharmacy Student Experiences in Medically Underserved Areas (0913)
- Pharmacy Expertise in the Preparation and Handling of Injectable Medications (0915)
- Continuing Professional Development (0916)
- Pharmacy Residency Training (0917)
- Collaboration Regarding Experiential Education (0804)
- Requirement for Residency (0701)
- Residency Programs (0704)
- ASHP Guidelines, Statements, and Professional Policies as an Integral Part of the Educational Process (0705)
- Communication Among Health-System Pharmacy Practitioners, Patients, and Other Health Care Providers (0510)
- Practice Sites for Colleges of Pharmacy (0315)
- Licensure for Pharmacy Graduates of Foreign Schools(0323)
- Public Funding for Pharmacy Residency Training (0325).
- Residency Training for Pharmacists Who Provide Direct Patient Care (0005)
- Career Counseling (8507)
- Endorsed Documents
- Definitions of Pharmacy Residencies and Fellowships
- Ethics
- Pharmacist Role in Capital Punishment (1531)
- Pharmacist's Role on Ethics Committees (1403)
- Ethical Use of Placebos in Clinical Practice (1116)
- Pharmacist's Right of Conscience and Patient's Right of Access to Therapy (0610)
- Patient's Right to Choose (0013)
- ASHP Position on Assisted Suicide (9915)
- Nondiscriminatory Pharmaceutical Care (9006)
- ASHP Statement on Leadership as a Professional Obligation
- ASHP Statement on Pharmacist's Decision-making on Assisted Suicide
- ASHP Statement on Professionalism
- ASHP Guidelines on Pharmacists' Relationships with Industry
- Endorsed Document
- Code of Ethics for Pharmacists
- Formulary Management (Medication-Use Policy Development)
- Pharmacogenomics (1104)
- Medications Derived from Biologic Sources (0809)
- Generic Substitution of Narrow Therapeutic Index Drugs (0817)
- Expression of Therapeutic Purpose of Prescribing (0305)
- Appropriate Dosing of Medications in Patient Populations with Unique Needs (0228)
- Medication Formulary System Management (0102)
- Gene Therapy (0103)
- Role of Pharmacists and Business Leaders in Health Care Services and Policies (9819)
- Standardization of Drug Medication Formulary Systems (9601)
- Medical Devices (9106)
- Therapeutic Interchange (8708)
- ASHP Statement on the Pharmacy and Therapeutics Committee and the Formulary System
- ASHP Statement on the Use of Medications for Unlabeled Uses
- ASHP Guidelines on Medication-Use Evaluation
- ASHP Guidelines on the Pharmacy and Therapeutics Committee and the Formulary System
- Endorsed Document.
- Principles of a Sound Drug Formulary System
- Government, Law, and Regulation
- Drug Product Supply Chain Integrity (1602)
- Timely Board of Pharmacy Licensing (1621)
- Inclusion of Drug Product Shortages in State Price-gouging Laws (1622)
- Pharmacist Participation in Health Policy Development (1501)
- Pharmacist Recognition as a Healthcare Provider (1502)
- Premarketing Comparative Clinical Studies (1506)
- Funding, Expertise, and Oversight of State Boards of Pharmacy (1507)
- Support for FDA Expanded Access (Compassionate Use) Program (1508)
- Approval of Biosimilar Medications (1509)
- Development of Abuse-Resistant Narcotics (1512)
- Quality Patient Medication Information (1513)
- Automatic Stop Orders (1405)
- Federal and State Regulation of Compounding (1406)
- 340B Drug Pricing Program Sustainability (1407)
- State Prescription Drug Monitoring Programs (1408)
- Access to Oral Contraceptives Through an Intermediate Category of Drug Products (1410)
- Expedited Pathways for FDA Drug Approval (1411)
- FDA Oversight of Laboratory-Developed Tests (1412)
- Regulation of Telepharmacy Services (1310)
- Regulation of Centralized Order Fulfillment (1311)
- DEA Scheduling of Hydrocodone Combination Products (1314)
- DEA Scheduling of Controlled Substances (1315)
- Pharmacy Technicians (1216)
- Stable Funding for HRSA Office of Pharmacy Affairs (1219)
- Globalization of Clinical Trials (1223)
- Medical Marijuana (1101)
- Agricultural Use of Hormone and Prohormone Therapies (1102)
- Direct-to-Consumer Clinical Genetic Tests (1103)
- Poison Control Center Funding (1121)
- Health Insurance Coverage for U.S. Residents (1001)
- Risk Evaluation and Mitigation Strategies (1002)
- FDA Authority on Recalls (1003)
- Postmarketing Comparative Clinical and Pharmacoeconomic Studies (1004).
- Regulation of Home Medical Equipment Medication Products and Devices (1007).
- Notes:
- Includes index.
- Description based on online resource; title from PDF cover (ebrary, viewed November 11, 2016).
- Description based on publisher supplied metadata and other sources.
- ISBN:
- 1-58528-584-6
- 1-58528-583-8
- OCLC:
- 962157205
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.